| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
|
| [2] |
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1): 12-49. DOI: 10.3322/caac.21820.
|
| [3] |
Oktay K, Harvey BE, Partridge AH, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update[J]. J Clin Oncol, 2018, 36(19): 1994-2001. DOI: 10.1200/JCO.2018.78.1914.
|
| [4] |
Taylan E, Oktay K. Fertility preservation in gynecologic cancers[J]. Gynecol Oncol, 2019, 155(3): 522-529. DOI: 10.1016/j.ygyno.2019.09.012.
|
| [5] |
Di Nisio V, Daponte N, Messini C, et al. Oncofertility and fertility preservation for women with gynecological malignancies: where do we stand today？[J]. Biomolecules, 2024, 14(8)：943. DOI: 10.3390/biom14080943.
|
| [6] |
Schuurman T, Zilver S, Samuels S, et al. Fertility-sparing surgery in gynecologic cancer: a systematic review[J]. Cancers (Basel), 2021, 13(5)：1008. DOI: 10.3390/cancers13051008.
|
| [7] |
Markowska A, Antoszczak M, Markowska J, et al. Gynotoxic effects of chemotherapy and potential protective mechanisms[J]. Cancers (Basel), 2024, 16(12)：2288. DOI: 10.3390/cancers16122288.
|
| [8] |
Ghadjar P, Budach V, Köhler C, et al. Modern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiation[J]. Radiat Oncol, 2015, 10: 50. DOI: 10.1186/s13014-015-0353-4.
|
| [9] |
Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion[J]. Fertil Steril, 2019, 112(6): 1022-1033. DOI: 10.1016/j.fertnstert.2019.09.013. |
| [10] |
ESHRE Guideline Group on Female Fertility Preservation. ESHRE guideline: female fertility preservation[J]. Hum Reprod Open, 2020, 2020(4): hoaa052. DOI: 10.1093/hropen/hoaa052. |
| [11] |
Su HI, Lacchetti C, Letourneau J, et al. Fertility preservation in people with cancer: ASCO guideline update[J]. J Clin Oncol, 2025, 43(12): 1488-1515. DOI: 10.1200/JCO-24-02782.
|
| [12] |
|
| [13] |
Melin J, Holopainen E, Savolainen-Peltonen H. Fertility counselling and fertility preservation among early onset female cancer patients-A Finnish register-based study[J]. Cancer Med, 2024, 13(3): e7034. DOI: 10.1002/cam4.7034.
|
| [14] |
中国优生科学协会肿瘤生殖学分会，中国医师协会微无创医学专业委员会妇科肿瘤学组，中国医院协会妇产医院分会妇科肿瘤专业学组. 卵巢恶性肿瘤保留生育功能的中国专家共识(2022年版)[J]. 中国实用妇科与产科杂志， 2022, 38(7): 705-713. DOI: 10.19538/j.fk2022070110. |
| [15] |
Woolderink JM, De Bock GH, de Hullu JA, et al. Characteristics of Lynch syndrome associated ovarian cancer[J]. Gynecol Oncol, 2018, 150(2): 324-330. DOI: 10.1016/j.ygyno.2018.03.060.
|
| [16] |
Nikiforov D, Junping C, Cadenas J, et al. Improving the maturation rate of human oocytes collected ex vivo during the cryopreservation of ovarian tissue[J]. J Assist Reprod Genet, 2020, 37(4): 891-904. DOI: 10.1007/s10815-020-01724-7.
|
| [17] |
Fraison E, Huberlant S, Labrune E, et al. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and Meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation[J]. Hum Reprod, 2023, 38(3): 489-502. DOI: 10.1093/humrep/deac249.
|
| [18] |
Kuang Y, Hong Q, Chen Q, et al. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles[J]. Fertil Steril， 2014， 101(1)：105-111. DOI： 10.1016/j.fertnstert.2013.09.007.
|